SSA
WVE icon

Schonfeld Strategic Advisors’s Wave Life Sciences WVE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-102,635
Closed -$512K – 2469
2024
Q2 		$512K Buy
+102,635
New +$586K ﹤0.01% 1477
2023
Q2 		– Sell
-11,200
Closed -$48.5K – 2549
2023
Q1 		$48.5K Buy
+11,200
New +$51.3K ﹤0.01% 1772
2020
Q4 		– Sell
-48,000
Closed -$408K – 1914
2020
Q3 		$408K Sell
48,000
-24,100
-33% -$264K 0.01% 982
2020
Q2 		$750K Buy
+72,100
New +$678K 0.02% 692
2019
Q2 		– Sell
-67,000
Closed -$2.6M – 1278
2019
Q1 		$2.6M Buy
67,000
+47,000
+235% +$1.91M 0.09% 281
2018
Q4 		$841K Hold
20,000
– – 0.03% 520
2018
Q3 		$1M Sell
20,000
-10,000
-33% -$451K 0.04% 430
2018
Q2 		$1.15M Sell
30,000
-10,163
-25% -$437K 0.06% 371
2018
Q1 		$1.61M Sell
40,163
-44,193
-52% -$1.86M 0.12% 237
2017
Q4 		$2.96M Buy
+84,356
New +$2.46M 0.24% 125

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Schonfeld Strategic Advisors's WVE Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Wave Life Sciences (WVE) in Q3 2024, closing a stake of 102,635 shares — an estimated $512K sold.

Schonfeld Strategic Advisors first reported a position in WVE in Q4 2017 and held it in 10 quarters. The position peaked at $2.96M in Q4 2017. 162 funds tracked by Wall St. Rank hold WVE as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Wave Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 102,635 Wave Life Sciences shares in Q3 2024, an estimated $512K.
  • Schonfeld Strategic Advisors first reported a position in Wave Life Sciences in Q4 2017 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Wave Life Sciences position peaked at $2.96M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.